The New England Journal of Medicine, 375(4), 311-322
This approach reduced gastrointestinal side effects and improved tolerability
This study aimed to compare the impacts of starting GLP-1-RAs versus dipeptidyl peptidase-4 inhibitors (DPP-4is), like linagliptin (Tradjenta) on the risk of heart attacks, strokes, and death among patients with various autoimmune diseases and type 2 diabetes
The ADA and the European Association for the Study of Diabetes (EASD) recommend GLP-1 RAs (or SGLT2 inhibitors) with proven cardiovascular benefit for T2D patients with cardiovascular disease
Our new outpatient Interventional Radiology Center serves our patients in Columbus, OH and the central Ohio region
All transactions are processed through a secure, PCI DSScompliant system to ensure your data is fully protected